erbitux® (cetuximab, human/mouse chimeric anti-egfr monoclonal antibody (ImClone Inc)
90
Structured Review
ImClone Inc
erbitux® (cetuximab, human/mouse chimeric anti-egfr monoclonal antibody
Erbitux® (Cetuximab, Human/Mouse Chimeric Anti Egfr Monoclonal Antibody, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-human+egfr+antibody+erbitux/cetuximab+erbitux/us08257706-927-62-70
Average 90 stars, based on 1 article reviews
Erbitux® (Cetuximab, Human/Mouse Chimeric Anti Egfr Monoclonal Antibody, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-human+egfr+antibody+erbitux/cetuximab+erbitux/us08257706-927-62-70
Average 90 stars, based on 1 article reviews
erbitux® (cetuximab, human/mouse chimeric anti-egfr monoclonal antibody - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells. Article Snippet: We previously demonstrated that pancreatic adenocarcinoma BxPC-3 xenografts display resistance to treatment with Erbitux, gemcitabine, and radiation, whereas MIA PaCa-2 xenografts are highly sensitive to the same therapy.. Here, we elucidate in vitro mechanisms that may explain the observed differential response of epidermal growth factor receptor (EGFR) expressing pancreatic adenocarcinoma xenografts to Erbitux-based combination therapy in vivo.. MIA PaCa-2 and BxPC-3 protein lysates were probed with antibodies to EGFR, ErbB2, ErbB3, and ErbB4. |